National

Indigenous Truenat HPV Test Validation

Published on 13 Jun 2026

← Back to Current Affairs
Indigenous Truenat HPV Test Validation
  • Researchers from AIIMS New Delhi, ICMR, and WHO’s IARC have validated India’s indigenous Truenat HR-HPV-Plus test, meeting international standards for cervical cancer screening. Developed by Molbio Diagnostics, it detects eight high-risk HPV types responsible for nearly 95% of cervical cancers.
  • The test is affordable, point-of-care, and suitable for district-level facilities. While vaccination prevents future infections, screening remains crucial for women above 30. This breakthrough reduces dependence on expensive imports and supports India’s cervical cancer elimination goals through accessible early detection.
Source: SarkariPariksha